Mario Negri Institute For Pharmacological Research

This study looks back at medical records from 70 adults with advanced polycystic kidney disease (stage IV) who are taking the drug octreotide LAR. The goal is to find out which early signs, like kidney size and lab results, best predict how fast kidney function will drop over tim…

This study is part of a European project to improve how doctors diagnose and monitor two rare kidney diseases: aHUS and C3G. Researchers will develop new lab tests and study blood, cells, and kidney tissue from 180 patients and healthy volunteers. The goal is to find better marke…